Wave Life Sciences Ltd.
NASDAQWave Life Sciences heads into its May 8 earnings with one dominant story: a $55 million insider buying cluster that now looks increasingly misaligned with where the stock and analyst targets sit. The most compelling setup is the ownership signal. RA Capital Management — Wave's largest institutional shareholder and a board-represented 10% owner — spent more than $55 million buying…
Snapshot as of 7 May 2026
Wave Life Sciences heads into its May 8 earnings with one dominant story: a $55 million insider buying cluster that now looks increasingly misaligned with where the stock and analyst targets sit. The most compelling…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for WVE — free to start on ORTEX.
Sign up for free →Open WVE on ORTEX